Correlation Between Spyre Therapeutics and NET Power

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and NET Power at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and NET Power into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and NET Power, you can compare the effects of market volatilities on Spyre Therapeutics and NET Power and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of NET Power. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and NET Power.

Diversification Opportunities for Spyre Therapeutics and NET Power

0.42

Correlation Coefficient

Spyre Therapeutics  NET Power

Very weak diversification

The 3 months correlation between Spyre and NET is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and NET Power in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NET Power and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with NET Power. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NET Power has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and NET Power go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and NET Power

Given the investment horizon of 90 days Spyre Therapeutics is expected to generate 1.34 times less return on investment than NET Power. But when comparing it to its historical volatility, Spyre Therapeutics is 1.36 times less risky than NET Power. It trades about 0.07 of its potential returns per unit of risk. NET Power is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  316.00  in NET Power on July 14, 2025 and sell it today you would earn a total of  60.00  from holding NET Power or generate 18.99% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Spyre Therapeutics  vs.  NET Power

Spyre Therapeutics

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in Spyre Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Spyre Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

NET Power

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in NET Power are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, NET Power reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Spyre Therapeutics and NET Power

The main advantage of trading using opposite Spyre Therapeutics and NET Power positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, NET Power can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NET Power will offset losses from the drop in NET Power's long position.

The idea behind Spyre Therapeutics and NET Power pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..